Fair drug prices and the patent system

Health Care Analysis

Volumn 12, Issue 2, 2004, Pages 91-115

  Resnik, David B ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Developing nations; Fairness; HIV AIDS; John Rawls; Justice; Pharmaceutical patents; TRIPS agreement

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL RESEARCH; COMMERCIAL PHENOMENA; DRUG COST; DRUG INDUSTRY; ECONOMIC ASPECT; FOOD AND DRUG ADMINISTRATION; HEALTH CARE ORGANIZATION; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEGAL ASPECT; PATENT; PHILOSOPHY; POLITICS; PRESCRIPTION; RELIGION; REVIEW; ARTICLE; DRUG LEGISLATION; ETHICS; FEE; HEALTH CARE AND PUBLIC HEALTH; PHARMACOECONOMICS;

HEALTH CARE AND PUBLIC HEALTH;

DRUG INDUSTRY; ECONOMICS, PHARMACEUTICAL; ETHICAL ANALYSIS; LEGISLATION, DRUG; PATENTS; PRESCRIPTION FEES;

EID: 16644386468     PISSN: 10653058     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:HCAN.0000041185.52817.8c     Document Type: Review

References (53)

1. Angell, M. (2000) The Pharmaceutical Industry - To Whom is it Accountable? The New England Journal of Medicine 342, 1902-1904.
2. Beitz, C. (1998) International Justice: Conflict. In R. Chadwick, (Ed.), Encyclopedia of Applied Ethics (Vol. 2), pp. 871-874. New York: Academic.
3. Beitz, C. (1999) Political Theory and International Relations, (2nd ed.). Princeton, NJ: Princeton University Press.
4. Best-Online Pharmacy.com. (2003) Amoxycillin. Available at: http://www.best-online-pharmacies.com/prescription-drugs/prescription-drugs- amoxycillin.html
5. Bian, T. (1997) The Drug Lords: America's Pharmaceutical Cartel. New York: No Barriers.
6. Bildt, C. (2003, January 7) Fight Poverty, Not Patents. The Wall Street Journal, p. A13.
7. Blustein, P. (2003, February 1) Activists Hail President's Call for More Funding to Fight AIDS. The Washington Post, pp. A12.
8. Bodenheimer, T. (2000) Uneasy Alliance: Clinical Investigators and the Pharmaceutical Industry. The New England Journal of Medicine 342, 1539-1544.
9. Brody, B. (1995) Ethical Issues in Drug Testing, Approval, and Pricing. New York: Oxford University Press.
10. Brody, B. (1996) Public Goods and Fair Prices: Balancing Technological Innovation and Social Well Being. Hastings Center Report 26(2), 5-11.
11. Daniels, N. (1984) Just Health Care. Cambridge, UK: Cambridge University Press.
12. Diller, L. (1996) The Run on Ritalin: Attention Deficit Disorder and Stimulant Treatment in the 1990s. Hastings Center Report 26(2), 12-18.
13. Dworkin, G. (1988) The Theory and Practice of Autonomy. Cambridge, UK: Cambridge University Press.
14. Enserink, M. (2003) Bill Gates Plans a Hit List, with NIH's Help. Science 299, 641.
15. Goldhammer, A. (2001) Current Issues in Clinical Research and the Development of New Pharmaceuticals. Accountability in Research 8, 283-291.
16. Gutmann, A., and Thompson, D. (1996) Democracy and Disagreement. Cambridge, MA: Harvard University Press.
17. Harsanyi, J. (1975) Can the Maximin Principle Serve as a Basis for Morality? American Political Science Review 69, 594-606.
18. Harsanyi, I. (1976) Essays on Ethics, Social Behavior, and Scientific Explanation. Dordrecht, The Netherlands: Reidel.
19. Headden, S. (1997, September 1) The Big Pill Push. U.S. News and World Report, pp. 67-71.
20. Hewitt, W. (1967) Penicillin: Historical Impact on Infection Control. Annals of the New York Academy of Sciences 145, 212-215
21. King, R. (1997, Winter/Spring) The Evolution of Today's Calculator. International Calculator Collector 15/16, p. 1, 4. Available at: http://www.vintagecalculators.com/html/evolutionoftoday's-calculato.html
22. Lacayo, A. (2003) Seeking a Balance: International Pharmaceutical Patent Protection, Public Health Crises, and the Emerging Threat of Bio-terrorism. University of Miami International-American Law Review 33, 295-321.
23. Loff, B. (2002) World Trade Organization Wrestles with Access to Cheap Drugs Solution. The Lancet 360, 1670.
24. Manzer, J. (2002) Is Canada American's Favorite Drugstore? Medical Post 38(46), 1-5.
25. Marsa, L. (1999) Prescription for Profits: How the Pharmaceutical Industry Bankrolled the Unholy Marriage Between Science and Business. New York: Scribner. Mill, J.S. (1861 [1979]) Utilitarianism. Indianapolis, IN: Hackett.
26. Marsa, L. (1999) Prescription for Profits: How the Pharmaceutical Industry Bankrolled the Unholy Marriage Between Science and Business. New York: Scribner. Mill, J.S. (1861 [1979]) Utilitarianism. Indianapolis, IN: Hackett.
27. Miller, A., and Davis, M. (2000) Intellectual Property. St. Paul, MN: West.
28. Nerozzi, M. (2002) The Battle Over Life-Saving Pharmaceuticals: Are Developing Countries Being 'TRIPped' by Developed Countries? Villanova Law Review 47, 605-641.
29. Nozick, R. (1974) Anarchy, State, and Utopia. New York: Basic.
30. Obsolete Technology Website. (2003) Apple III. Available at: http://oldcomputers.net/appleiii.html
31. O'Neill, O. (1998) International Justice: Distribution. In R. Chadwick, (Ed.)., Encyclopedia of Applied Ethics, (Vol. 2), pp. 874-877. New York: Academic.
32. Pear, R. (2002, December 25) Law Requiring Lower Drag Prices in Struck Down. The New York Times, p. A1.
33. Pear, R. (2003, January 3) Bush May Link Drug Benefit in Medicare to Private Plans. The New York Times, p. A1.
34. Pharmaceutical Research and Manufacturing Association (PhRMA). (2003a) Research and Development. Washington, DC: PhRMA. Available at: www.phrma.org
35. Pharmaceutical Research and Manufacturing Association (PhRMA). (2003b) Intellectual Property. Washington, DC: PhRMA. Available at: www.phrma.org
36. Plato. (1974 [circa 400 BC]) The Republic. (G. Grube, (transl). Indianapolis, IN: Hackett.
37. Rawls, J. (1971) A Theory of Justice. Cambridge, MA: Harvard University Press.
38. Rawls, J. (1993) Political Liberalism. New York: Columbia University Press.
39. Rawls, J. (1999) The Law of the Peoples. Cambridge, MA: Harvard University Press.
40. Rawls, J. (2002) Justice As Fairness: A Restatement. E. Kelly, (Ed.). Cambridge, MA: Harvard University Press.
41. Reich, M. (2000) The Global Drug Gap. Science 287, 1979-1981.
42. Resnik, D. (2001) Developing Drugs for the Developing World: An Economic, Legal, Moral, and Political Dilemma. Developing World Bioethics 1, 11-32.
43. Resnik, D., and De Ville, K. (2002) Bioterrorism and Patent Rights: Compulsory Licensure and the Case of Cipro. American Journal of Bioethics 2(3), 29-39.
44. Resnik, M. (1987) Choice: An Introduction to Decision Theory. Minneapolis: University of Minnesota Press.
45. Samuelson, P. (1980) Economics (11th ed.). New York: McGraw-Hill.
46. Sandel, M. (1982) Liberalism and the Limits of Justice. Cambridge, UK: Cambridge University Press.
47. Schaafsma, P. (1997) An Economic Overview of Patents. Journal of the Patent and Trademark Office Society 79, 241-257.
48. Shamoo, A., and Resnik, D. (2002) Responsible Conduct of Research. New York: Oxford University Press.
49. Singer, P. (1972) Famine, Affluence, and Morality. Philosophy and Public Affairs 1, 229-243.
50. Stolberg, S. (2003, February 2) The White House Gets Religion on AIDS in Africa. The New York Times, p. A1.
51. Stolberg, S., and Gerth, J. (2000, April 23) Medicine Merchants: Holding Down the Competition. The New York Times, p. A1.
52. U.S. Constitution. (1787) Article 1, Section 8, Clause 8.
53. Wreen, M. (1998) Patents. In R. Chadwick, (Ed.), Encyclopedia of Applied Ethics (Vol. 3), New York: Academic, pp. 435-447.